Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $147.4 million.

  • Autolus Therapeutics' Non-Current Assets rose 3473.71% to $147.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.5 million, marking a year-over-year increase of 3606.68%. This contributed to the annual value of $121.8 million for FY2024, which is 2169.99% up from last year.
  • Autolus Therapeutics' Non-Current Assets amounted to $147.4 million in Q3 2025, which was up 3473.71% from $146.7 million recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Non-Current Assets high stood at $147.4 million for Q3 2025, and its period low was $51.5 million during Q3 2022.
  • In the last 5 years, Autolus Therapeutics' Non-Current Assets had a median value of $95.0 million in 2024 and averaged $88.1 million.
  • Per our database at Business Quant, Autolus Therapeutics' Non-Current Assets tumbled by 3973.66% in 2021 and then skyrocketed by 8966.98% in 2023.
  • Over the past 5 years, Autolus Therapeutics' Non-Current Assets (Quarter) stood at $58.6 million in 2021, then rose by 10.06% to $64.5 million in 2022, then surged by 55.15% to $100.1 million in 2023, then rose by 21.7% to $121.8 million in 2024, then increased by 21.0% to $147.4 million in 2025.
  • Its Non-Current Assets was $147.4 million in Q3 2025, compared to $146.7 million in Q2 2025 and $130.6 million in Q1 2025.